Abstract
Left ventricular assist devices (LVAD) for mechanical circulatory support (MCS) has proven to be a suitable alternative to heart transplantation for patients as a bridge to transplantation (BTT) or destination therapy (DT) in patients who are not candidates for transplantation. Specific and nonspecific infections related to these devices have serious implications on the function of the device, mortality rates of the patients, and future prognosis following further treatment. Numerous risk factors, such as age, obesity, nutrition profile, and comorbidities, play a role in predicting these infections.
| Original language | English (US) |
|---|---|
| Title of host publication | Infective Endocarditis |
| Subtitle of host publication | A Multidisciplinary Team Approach to a Complex Disease |
| Publisher | Springer Science+Business Media |
| Pages | 665-676 |
| Number of pages | 12 |
| ISBN (Electronic) | 9783031658396 |
| ISBN (Print) | 9783031658389 |
| DOIs | |
| State | Published - Jan 1 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
- General Neuroscience
Fingerprint
Dive into the research topics of 'Ventricular Assist Device Infections'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver